Subcutaneous Administration of Otelixizumab to T1DM Patients (RAO112438)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00946257
First received: July 23, 2009
Last updated: May 29, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)